In another report from the Central Drugs Standard Control Organisation (CDSCO), sixteen drug samples produced in Himachal Pradesh have failed quality tests. The CDSCO identified these samples as "not of standard quality" in an alert issued for August.

"These drugs address a range of conditions, including bacterial infections of the gut, blood clots, pain and inflammation, allergies, acidity, high blood pressure, arthritis, headaches, chronic bronchitis, heart failure, indigestion, nausea, vomiting, stomach ulcers, cough, and antifungal infections."

This comes after the CDSCO yesterday reported that 48 drugs, including common medications like paracetamol and vitamin D3 supplements, have also been classified as "not of standard quality." Some pharmaceutical companies have disputed these findings, claiming the drugs in question are spurious, as determined through random monthly sampling by state drug officers.

The affected drugs, manufactured primarily in the Baddi industrial area of Solan district and the Kala Amb industrial area of Sirmaur district, are used for various health issues, including bacterial infections, diabetes, diarrhea, allergies, body pain, and blood clots. This is part of a larger concern, as CDSCO has flagged a total of 48 drug samples from across the country for being substandard in August alone.

According to Himachal Pradesh’s drug control administration (DCA), the drugs that failed the quality tests will be withdrawn from the market, and notices will be issued to the manufacturers. This follows a troubling trend, as 16 drugs were also reported to have failed CDSCO tests in July. Since January, 97 drug samples from Himachal have been deemed substandard, and in 2023, a total of 120 drugs produced in the state did not meet quality standards.

Himachal Pradesh is home to around 660 pharmaceutical companies, with the majority located in Baddi, one of India's largest pharmaceutical hubs. Additional production units can be found in Parwanoo and Nalagarh in Solan district, as well as Kala Amb in Sirmaur district.

In related news, the CDSCO has recently reported that nearly 50 drugs, including common medications like paracetamol and vitamin D3 supplements, have also been classified as "not of standard quality." Some pharmaceutical companies have disputed these findings, claiming the drugs in question are spurious, as determined through random monthly sampling by state drug officers.

Furthermore, in Indore, the Pollution Control Board has collected over 20 water samples from Jawahar Tekri and nearby areas to assess water quality before and after Ganesh idol immersions. Initial results have shown satisfactory conditions, though heavy metal analysis is still pending.

In a separate issue, recent raids by Telangana's Drugs Control Administration uncovered illegal drug manufacturing occurring under food licenses. Products such as Pedi Zinc Syrup and Ferrorus-XT tablets were found being sold without the necessary drug licenses, breaching the Drugs and Cosmetics Act. These unregulated products often lack active ingredients and pose significant health risks.

Here's the Full List of 48 Drugs That Failed Quality Tests, Check Here...

Indian Pharma Companies Under Scrutiny as 53 Drugs Fail Quality Tests